Literature DB >> 34204372

Current Perspectives on the Role of Matrix Metalloproteinases in the Pathogenesis of Basal Cell Carcinoma.

Mircea Tampa1,2, Simona Roxana Georgescu1,2, Madalina Irina Mitran3, Cristina Iulia Mitran3, Clara Matei1, Ana Caruntu4,5, Cristian Scheau6, Ilinca Nicolae2, Andreea Matei6, Constantin Caruntu6,7, Carolina Constantin8,9, Monica Neagu8,9,10.   

Abstract

Basal cell carcinoma (BCC) is the most common skin malignancy, which rarely metastasizes but has a great ability to infiltrate and invade the surrounding tissues. One of the molecular players involved in the metastatic process are matrix metalloproteinases (MMPs). MMPs are enzymes that can degrade various components of the extracellular matrix. In the skin, the expression of MMPs is increased in response to various stimuli, including ultraviolet (UV) radiation, one of the main factors involved in the development of BCC. By modulating various processes that are linked to tumor growth, such as invasion and angiogenesis, MMPs have been associated with UV-related carcinogenesis. The sources of MMPs are multiple, as they can be released by both neoplastic and tumor microenvironment cells. Inhibiting the action of MMPs could be a useful therapeutic option in BCC management. In this review that reunites the latest advances in this domain, we discuss the role of MMPs in the pathogenesis and evolution of BCC, as molecules involved in tumor aggressiveness and risk of recurrence, in order to offer a fresh and updated perspective on this field.

Entities:  

Keywords:  BCC; MMP; TIMP; invasion; tumor progression

Year:  2021        PMID: 34204372     DOI: 10.3390/biom11060903

Source DB:  PubMed          Journal:  Biomolecules        ISSN: 2218-273X


  8 in total

Review 1.  Role of matrix metalloproteinase in wound healing.

Authors:  Mimansa Kandhwal; Tapan Behl; Sukhbir Singh; Neelam Sharma; Sandeep Arora; Saurabh Bhatia; Ahmed Al-Harrasi; Monika Sachdeva; Simona Bungau
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

Review 2.  Matrix Effectors in the Pathogenesis of Keratinocyte-Derived Carcinomas.

Authors:  Rafaela-Maria Kavasi; Monica Neagu; Carolina Constantin; Adriana Munteanu; Mihaela Surcel; Aristidis Tsatsakis; George N Tzanakakis; Dragana Nikitovic
Journal:  Front Med (Lausanne)       Date:  2022-04-29

Review 3.  Basal Cell Carcinoma: Pathology, Current Clinical Treatment, and Potential Use of Lipid Nanoparticles.

Authors:  Izabela Łasińska; Aleksandra Zielińska; Jacek Mackiewicz; Eliana B Souto
Journal:  Cancers (Basel)       Date:  2022-06-03       Impact factor: 6.575

Review 4.  Progress of Nanomaterials in Photodynamic Therapy Against Tumor.

Authors:  Lei Chen; Jiahui Huang; Xiaotong Li; Miaoting Huang; Shaoting Zeng; Jiayi Zheng; Shuyi Peng; Shiying Li
Journal:  Front Bioeng Biotechnol       Date:  2022-05-31

5.  Investigation of the relationship between MMP-1 (- 1607 1G/2G), MMP-3 (- 1171 5A/6A) gene variations and development of bladder cancer.

Authors:  Arzu Ay; Nevra Alkanli; Gokhan Cevik
Journal:  Mol Biol Rep       Date:  2021-10-25       Impact factor: 2.316

6.  Doxycycline Attenuates Doxorubicin-Induced Cardiotoxicity by Improving Myocardial Energy Metabolism in Rats.

Authors:  Danielle Dantas; Amanda Gomes Pereira; Anderson Seiji Soares Fujimori; Ana Paula Dantas Ribeiro; Carol Cristina Vágula de Almeida Silva; Marina Gaiato Monte; Camila Renata Corrêa; Ana Angélica Fernandes; Silmeia Garcia Zanati Bazan; Paula Schmidt Azevedo; Marcos Ferreira Minicucci; Sergio Alberto Rupp de Paiva; Leonardo Antônio Mamede Zornoff; Bertha Furlan Polegato
Journal:  J Cardiovasc Dev Dis       Date:  2022-08-08

Review 7.  Lumican in Carcinogenesis-Revisited.

Authors:  Eirini-Maria Giatagana; Aikaterini Berdiaki; Aristidis Tsatsakis; George N Tzanakakis; Dragana Nikitovic
Journal:  Biomolecules       Date:  2021-09-06

8.  Preface of the Special Issue on the Role of Extracellular Matrix in Development and Cancer Progression.

Authors:  George Tzanakakis; Dragana Nikitovic
Journal:  Biomolecules       Date:  2022-02-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.